Concepedia

Publication | Open Access

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis

DOIFull Paper Access

329

Citations

37

References

2020

Year

Emma Guttman‐Yassky, Andrew Blauvelt, Lawrence F. Eichenfield, Amy S. Paller, April W. Armstrong, Janice Drew, Ramanan Gopalan, Eric L. Simpson
JAMA Dermatology

Abstract

ClinicalTrials.gov Identifier: NCT03443024.

References

YearCitations

Page 1